Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

NCT06409481 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

800000

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Cardiac Diseases
Vascular Diseases
Cancer

Interventions

DRUG: Antineoplastic Agents

Sponsor

The First Affiliated Hospital of Xinxiang Medical College